A MUM has told how her symptoms were dismissed as being all “in her head” before she was diagnosed with one of the world’s ...
(SystImmune) and Bristol Myers Squibb announced that SystImmune?s parent company Sichuan Biokin Pharmaceutical Ltd. (Biokin) reported positive results from a prespecified interim analysis of the ...
“To say I was shocked would be an understatement,” Mary Ann Thomas recalls to PEOPLE ...
ELAHERE ® is an antibody-drug conjugate (ADC) indicated for the treatment of folate receptor-alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer ...
Sofetabart mipitecan (Sofe-M), an investigational folate receptor α (FRα)–directed antibody-drug conjugate (ADC), yielded ...
4d
Girl, 10, Shares Her Ovarian Cancer Journey: ‘During Scary Times, You Have to Be Brave’ (Exclusive)
Meher Shukla, shares her ovarian cancer journey, from diagnosis and chemotherapy to surgery that preserved her future ...
Azenosertib Shows 15.8-Month Overall Survival in Cyclin E1-Positive Ovarian Cancer / Azenosertib, biomarker-driven therapy, ...
Stories by SWNS on MSN
Mum’s ‘bleeding from perimenopause’ was sign of rare cancer
A mum’s bleeding was dismissed as perimenopause and told it was all “in her head” before she was diagnosed with one of the ...
RSVP Live on MSN
Mum's perimenopause bleeding turned out to be rare cancer
Nicola Crymble was repeatedly told her symptoms were linked to perimenopause and anxiety ...
HRDPath, an AI model, analyzes tissue images to identify ovarian cancers with homologous recombination deficiency.
Then she had a hysterectomy during winter break. The surgeon left her ovaries intact during that procedure, but the pathology showed the cancer had been extremely close to her fallopian tubes, so she ...
The investigational folate receptor alpha (FRα)–targeted antibody-drug conjugate (ADC) sofetabart mipitecan (LY4170156) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results